Download the 2026 Economic Impact Report
Join Now
Join Now

Rymedi and Public Good Pharma Announce Strategic Partnership to Improve Access to Medicine by Leveraging Web3.0-backed Financial Innovation

Rymedi

Greenville, SC — Rymedi, a leader in clinical data management using blockchain technology, and Public Good Pharma (PGP) a financially-innovative biotech company established by Crowd Funded Cures, a registered charity and early DeSci pioneer, today announced a strategic partnership to revolutionize medicine accessibility.


Key Highlights of the Partnership:

  • Clinical Data Management: Rymedi hosts clinical trial data on the blockchain for secure, auditable, and immutable data handling while ensuring compliance with data protection laws, including GDPR. 
  • Interventional Pharmacoeconomics – Self-Funding Trials: PGP introduces a groundbreaking approach to develop low-cost alternatives to expensive patented drugs without financial risk through self-funding “interventional pharmacoecononomic” (IVPE) trials funded by the cost-savings of health insurers. 
  • Data-Driven and Ethical Drug Development: By leveraging Rymedi’s blockchain solutions, PGP will enhance drug discovery, focusing on its pipeline of low-cost alternatives to high-cost specialty drugs causing significant financial toxicity in underserved communities. 
  • Global Health Initiatives: Together, the companies will work on initiatives aimed at improving healthcare infrastructure in low-resource settings, including working with Med Aditus Pharmaceuticals, who have established a state-of-the-art continuous flow pharmaceutical manufacturing plant in Kenya, supporting PGP’s mission to deliver affordable medications.

David Stefanich, CEO of Rymedi: “Our partnership with Public Good Pharma marks a significant step forward in our mission to secure and utilize blockchain for the greater good. By combining our technologies, we aim to set a new standard in healthcare delivery where innovation and ethics go hand in hand.”


Savva Kerdemelidis, Founder & CEO of Public Good Pharma and Crowd Funded Cures: “Working with Rymedi allows us to ensure that our focus on accessible, affordable medicine is backed by the best and most secure data practices. This partnership will help us bring critical treatments to those who need them most, faster and more safely than ever before.”

About Rymedi:

Rymedi is a technology company focused on enhancing healthcare through secure data management, analytics, and blockchain technology. Their solutions are designed to empower healthcare providers to deliver better patient outcomes while maintaining the highest standards of data integrity, security and privacy, fully-compliant with data protection regulations.

About Public Good Pharma:

Public Good Pharma is a financially-innovative biotech company established by the pioneering DeSci charity, Crowd Funded Cures, developing affordable therapies using self-funding interventional pharmacoeconomic (IVPE) clinical trials and Pay-for-Success (PFS) contracts that leverage the cost-savings of health insurers. Their mission is to address global health inequities by helping finance the development of low-cost therapies that are overlooked by traditional pharmaceutical companies, including repurposed generic drugs, biosimilars, nutraceuticals, diets, and behavioral interventions.

For more information, please contact:

Rymedi: info@rymedi.com (mailto:info@rymedi.com)
Public Good Pharma: info@publicgoodpharma.org (mailto:info@publicgoodpharma.org)

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Join Today!

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.